bioRxiv Science⌕ Search

Biology subjects

Bost, P.

Publications and source records attributed to Bost, P..

7 recordsLinked to original sources

Exploiting pair correlation function to describe biological tissue structure

Multiplexed imaging technologies now enable the simultaneous profiling of hundreds to thousands of molecular targets in intact tissues, providing unprecedented insight into cellular heterogeneity and spatial organization. While data generation has rapidly matured, the quantitative analysis of spatial structure remains challenging and poorly standardized, particularly across biological length scales. Existing approaches, such as distance-based metrics, neighborhood analyses and graph neural networks, either capture only local interactions or sacrifice interpretability for predictive power. Here we introduce PCF-SiM (Pair Correlation Function Sigmoid Modeling), a scalable and interpretable framework that leverages parametric modeling of the pair correlation function to quantify spatial organization in multiplexed imaging data. PCF-SiM compresses complex spatial patterns into a small set of biologically meaningful parameters, enabling robust comparisons across cell types, samples and conditions. Applying PCF-SiM to diverse public spatial transcriptomics datasets, we demonstrate its ability to detect condition-dependent tissue remodeling in a mouse colitis model. We further extend the framework with a co-scaling strategy that identifies cell types participating in shared spatial structures. Using newly generated clinical datasets from Hashimotos thyroiditis and uveal melanoma liver metastases, PCF-SiM reveals hierarchical organization of autoimmune infiltrates and coordinated spatial interactions between lymphatic endothelial cells and tumor-infiltrating lymphocytes. Finally, we show that reliable inference of tissue-scale architecture requires whole-slide imaging, exposing intrinsic limitations of tumor microarray-based spatial analyses. Together, PCF-SiM provides a principled and interpretable approach for spatial analysis of multiplexed imaging data.

bioinformatics↗

Next generation statistical framework for next generation spatial transcriptomics data

The rapid advancement of spatial transcriptomic technologies, particularly in situ hybridization based methods, has enabled the profiling of gene expression at sub cellular resolution across large tissue sections. Commercial platforms such as Xenium and CosMx now routinely generate high-quality datasets of increasing size and complexity. However, existing analytical approaches, often adapted from single-cell genomics, fall short in addressing the specific challenges posed by spatial data, especially at scale. In this work, we present TranspaceR, a new R package that introduces computational and statistical methods tailored to the analysis of next-generation spatial transcriptomic datasets. Our framework includes novel quality control procedures, scalable gene selection strategies especially for spatially variable genes, and optimized normalization and dimensionality reduction techniques based on in-depth statistical characterization of spatial data. We also demonstrate how single-cell annotation tools can be leveraged for automated cell-type labeling within spatial contexts. Together, these tools enable the efficient and robust analysis of imaging-based spatial transcriptomics datasets comprising millions of cells, paving the way for deeper insights into tissue organization.

bioinformatics↗

Spatial proteomics with 100+ markers with Highly Multiplexed MALDI-IHC

Highly multiplexed, antibody-based protein imaging of tissue has yielded many insights but does not yet allow the routine analysis of more than 50 markers simultaneously. By leveraging the ability of Matrix-Assisted Laser Desorption/Ionization (MALDI) imaging to resolve hundreds of m/z peaks without spectral overlap, MALDI-IHC with photocleavable mass-tag (PCMT)-labelled antibodies offers the possibility to dramatically increase the number of markers that can be imaged. Here, we demonstrate 100+ plex MALDI-IHC imaging and describe our development of gutenTAG, an open-source analysis pipeline for the resulting highly multiplex data. We validated a panel of 133 tumor-ecosystem-focused antibodies, show that it captures expected histopathology in diverse tissues, and demonstrate reproducibility of the method. We further applied a 120-plex subset of this panel to samples from an endometrial cancer cohort, again capturing expected histopathology and identifying novel spatial structures between TCGA molecular subtypes. Our work demonstrates the feasibility of simultaneously detecting hundreds of protein markers in a reproducible and scalable manner.

systems biology↗

Statistical modeling and analysis of multiplexed imaging data

The rapid development of multiplexed imaging technologies has enabled the spatial cartography of various healthy and tumor tissues. However, the lack of adequate statistical models has hampered the use of multiplexed imaging to efficiently compare tissue composition across sample groups, for instance between healthy and tumor tissue samples. Here, we developed two statistical models that accurately describe the distribution of cell counts observed in a given field of view in an imaging experiment. The parameters of these distributions are directly linked to the field of view size and also to properties of the studied cell type such as cellular density and spatial aggregation. Using these models, we identified statistical tests that have improved statistical power for differential abundance testing of tissue composition compared to the commonly used rank-based test. Our analysis revealed that spatial aggregation is the main determinant of statistical power and that to have sufficient power to detect differences in cell counts when cells are highly aggregated may require sampling of hundreds of fields of view. To overcome this challenge, we provide a new stratified sampling strategy that might significantly reduce the number of required samples.

bioinformatics↗

Optimizing multiplexed imaging experimental design through tissue spatial segregation estimation

Recent advances in multiplexed imaging methods allow simultaneous detection of dozens of proteins and hundreds of RNAs enabling deep spatial characterization of both healthy and diseased tissues. Parameters for design of optimal sequencing-based experiments have been established, but such parameters, especially those estimating how much area has to be imaged to capture all cell phenotype clusters, are lacking for multiplex imaging studies. Here, using a spatial transcriptomic atlas of healthy and tumor human tissues, we developed a new statistical framework that determines the number and area of fields of view necessary to accurately identify all cell types that are part of a tissue. Using this strategy on imaging mass cytometry data, we identified a measurement of tissue spatial segregation that enables optimal experimental design. This strategy will enable significantly improved design of multiplexed imaging studies.

bioinformatics↗

Differential levels of IFNα subtypes in autoimmunity and viral infection

Type I interferons are essential for host response to viral infections, while dysregulation of their response can result in autoinflammation or autoimmunity. Among IFN (alpha) responses, 13 subtypes exist that signal through the same receptor, but have been reported to have different effector functions. However, the lack of available tools for discriminating these closely related subtypes, in particular at the protein level, has restricted the study of their differential roles in disease. We developed a digital ELISA with specificity and high sensitivity for the IFN2 subtype. Application of this assay, in parallel with our previously described pan-IFN assay, allowed us to study different IFN protein responses following cellular stimulation and in diverse patient cohorts. We observed different ratios of IFN protein responses between viral infection and autoimmune patients. This analysis also revealed a small percentage of autoimmune patients with high IFN2 protein measurements but low pan-IFN measurements. Correlation with an ISG score and functional activity showed that in this small sub group of patients, IFN2 protein measurements did not reflect its biological activity. This unusual phenotype was partly explained by the presence of anti-IFN auto-antibodies in a subset of autoimmune patients. This study reports ultrasensitive assays for the study of IFN proteins in patient samples and highlights the insights that can be obtained from the use of multiple phenotypic readouts in translational and clinical studies.

immunology↗

Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses

Tuberculosis (TB) remains a major public health problem with host-directed therapeutics offering potential as novel treatment strategies. However, their successful development still requires a comprehensive understanding of how Mycobacterium tuberculosis (M.tb) infection impacts immune responses. To address this challenge, we applied standardised immunomonitoring tools to compare TB antigen, BCG and IL-1{beta} induced immune responses between individuals with latent M.tb infection (LTBI) and active TB disease, at diagnosis and after cure. This revealed distinct responses between TB and LTBI groups at transcriptomic, proteomic and metabolomic levels. At baseline, we identified pregnane steroids and the PPAR{gamma} pathway as new immune-metabolic drivers of elevated plasma IL-1ra in TB. We also observed dysregulated induced IL-1 responses after BCG stimulation in TB patients. Elevated IL-1 antagonist responses were explained by upstream differences in TNF responses, while for IL-1 agonists it was due to downstream differences in granzyme mediated cleavage. Finally, the immune response to IL-1{beta} driven signalling was also dramatically perturbed in TB disease but was completely restored after successful antibiotic treatment. This systems immunology approach improves our knowledge of how immune responses are altered during TB disease, and may support design of improved diagnostic, prophylactic and therapeutic tools.

immunology↗